Mpc    (DrugBank: -)

2 diseases
告示番号疾患名(ページ内リンク)臨床試験数
210単心室症1
211左心低形成症候群1

210. 単心室症 [臨床試験数:47,薬物数:54(DrugBank:23),標的遺伝子数:32,標的パスウェイ数:66
Searched query = "Single Ventricle", "SV", "Single ventricle heart defect", "Univentricular heart", "UVH", "Single ventricular circulation syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 47 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03079401
(ClinicalTrials.gov)
November 27, 20178/3/2017Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left VentricleMesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left VentricleHypoplastic Left Heart Syndrome;Atrioventricular CanalBiological: MPC; rexlemestrocel-LBoston Children's HospitalNULLRecruitingN/A5 YearsAll24Phase 1;Phase 2United States

211. 左心低形成症候群 [臨床試験数:20,薬物数:28(DrugBank:9),標的遺伝子数:5,標的パスウェイ数:13
Searched query = "Hypoplastic left heart syndrome", "HLHS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 20 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03079401
(ClinicalTrials.gov)
November 27, 20178/3/2017Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left VentricleMesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left VentricleHypoplastic Left Heart Syndrome;Atrioventricular CanalBiological: MPC; rexlemestrocel-LBoston Children's HospitalNULLRecruitingN/A5 YearsAll24Phase 1;Phase 2United States